Zu Produktinformationen springen
Retatruide 10mg
€58,99
Finest Quality Retatruide 10mg
COA TESTED
REASEARCH ONLY
not for human or vet use!
Retatrutide is an investigational peptide-based medication being studied primarily for obesity and metabolic disease. It acts as a triple receptor agonist, targeting GLP-1, GIP, and glucagon receptors.
Clinical trials have shown substantial reductions in body weight and improvements in several metabolic markers. However, retatrutide is still investigational and is not currently an approved medication.
Common adverse effects reported in clinical studies have mainly been gastrointestinal, including nausea, diarrhea, vomiting, and decreased appetite. Its long-term safety and overall benefit–risk profile continue to be evaluated in clinical trials.